Sonya Martin

Sonya Martin's work experience includes:

- Senior Director, US Medical Affairs, Neurotrophins at Dompé from August 2023 to present.

- Capability Onboarding & Field Excellence Lead, US Medical Affairs Oncology at AstraZeneca from June 2022 to July 2023.

- Director, Corporate Strategy at The Medical Affairs Company (TMAC) from January 2019 to June 2022.

- Director, Field Based Medical Programs at The Medical Affairs Company (TMAC) from February 2014 to January 2019.

- Medical Liaison at Forest Research Institute from December 2011 to February 2014.

- Medical Science Liaison at Novartis/ The Medical Affairs Company from June 2010 to December 2011.

- Senior Medical Information Associate at Shionogi USA, Inc. from May 2009 to June 2010.

- Adjunct Faculty/Post-Doctoral Fellow at Rutgers University from July 2008 to July 2009.

- Post-Doctoral Business Intelligence Fellow at Ortho-McNeil Pharmaceutical from July 2008 to May 2009.

Sonya Martin has a PharmD degree in Pharmacy from Mercer University. Sonya also holds an MBA degree in Healthcare from Mercer University's Stetson School of Business and Economics. Sonya completed their undergraduate studies at the University of Florida, where they earned a BS degree in Microbiology.